This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Anaxis Pharma Pty Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Carole Annie Schuster-Klein: Innovator in Sulphonamide Compounds
Introduction
Carole Annie Schuster-Klein is a notable inventor based in Parkville, Australia. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on sulphonamide compounds. Her research focuses on developing compounds that have the potential to treat necroptosis and inhibit MLKL.
Latest Patents
Carole holds 1 patent for her invention related to sulphonamide compounds. This patent encompasses compounds of formula (I) and includes various forms such as salts, solvates, tautomers, N-oxides, stereoisomers, polymorphs, and prodrugs. The implications of her work are crucial for advancing treatments in medical science.
Career Highlights
Carole is currently associated with Anaxis Pharma Pty Ltd, where she continues to push the boundaries of pharmaceutical research. Her dedication to innovation in drug development has positioned her as a key figure in her field.
Collaborations
Throughout her career, Carole has collaborated with esteemed colleagues such as Martin Brzozowski and John Thomas Feutrill. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Carole Annie Schuster-Klein's contributions to the field of sulphonamide compounds exemplify her commitment to innovation in pharmaceuticals. Her work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile